Zejula Coupons & Savings Card – Discount Prices from $8965.15
My prescription
Edit
100MG, Zejula (30 Capsules)
Select pharmacy
Walgreens
$8965.15
COUPON PRICEZejula savings card
Show this card to your pharmacistWalgreens
$8965.15
BIN
ID
PCN
GRP
019876
LH73E34460
CHIPPO
LHX
Powered by
Related PARP inhibitors prescriptions
More prescriptions for ovarian cancer
Related PARP inhibitors prescriptions
More prescriptions for ovarian cancer
Price history for Zejula
30 Capsules, 100MG
Average retail price for Zejula
Average SaveHealth price for Zejula
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Zejula dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100MG | 30 Capsules | $8965.15 | $298.84 |
Zejula Warnings
This medication comes with several important warnings to ensure its safe use. It is crucial to understand these risks and precautions and discuss any concerns with your healthcare provider.
Bone Marrow and Blood Cancer Risks: Although infrequent, treatment with Zejula (niraparib) has been linked to a condition called myelodysplastic syndrome (MDS) and a type of blood cancer known as acute leukemia. These issues may occur months or even years after beginning treatment. If you have any concerns about cancer risks, please consult your healthcare provider.
Low Blood Cell Counts: Zejula (niraparib) may lead to decreased levels of red blood cells, white blood cells, and platelets, increasing the risk of anemia, infections, and bleeding. Regular monitoring of blood cell counts is advised.
High Blood Pressure and Cardiac Concerns: This medication can elevate blood pressure, potentially requiring urgent medical attention. Regular blood pressure monitoring is essential, particularly at the start of treatment. If you have heart conditions like coronary artery disease or arrhythmias, closer monitoring may be necessary. Symptoms such as irregular heartbeat, severe headaches, fatigue, or dizziness should be reported to your provider immediately.
Posterior Reversible Encephalopathy Syndrome (PRES): There have been rare reports of a brain condition known as PRES in patients using Zejula (niraparib). Immediate medical attention is required if you experience symptoms such as sudden severe headaches, confusion, vision changes, or seizures. Discontinuation of the medication is necessary if PRES is diagnosed.
Pregnancy Risks: This medication can cause harm to an unborn child due to its DNA-damaging effects. If you are of childbearing potential, use effective birth control during treatment and for at least 6 months after stopping the medication. Notify your healthcare provider immediately if you or your partner becomes pregnant during this period.
Please ensure to discuss these points with your healthcare provider to manage and mitigate any potential risks effectively.
Zejula Side Effects
When taking this medication, you might experience some common side effects such as nausea, vomiting, loss of appetite, constipation, dry mouth, mouth sores, dizziness, headache, and trouble sleeping. These effects are often mild and manageable, but if they continue or worsen, consult your healthcare provider for advice. To ease nausea, consider taking the medication at bedtime or eating smaller meals. There are more serious side effects that, although rare, require immediate medical attention. These include bone marrow issues, which might lead to low blood cell counts, causing fatigue, easy bruising, or increased susceptibility to infections. Symptoms to watch for include persistent sore throat, fever, unusual tiredness, pale skin, or abnormal bleeding. Additionally, this medication can occasionally cause high blood pressure and heart rate, so regular monitoring is advised. In rare instances, the medication may lead to posterior reversible encephalopathy syndrome (PRES), characterized by severe headaches, seizures, or sudden changes in vision or mental state. Seek urgent care if these symptoms occur. Allergic reactions are also rare but serious; signs include rash, swelling, severe dizziness, or difficulty breathing. Lastly, kidney problems and other side effects such as diarrhea, rash, and cough might occur, and any unusual symptoms should be reported to your healthcare provider.
Zejula Interactions
When taking Zejula (niraparib), it's important to be aware of potential interactions with other medications and substances:
Blood Pressure Medications: Zejula may increase blood pressure. If you're on antihypertensive drugs, your doctor may need to monitor your blood pressure more closely and adjust medications as necessary.
Medications Affecting Blood Cell Counts: Zejula can lower blood cell counts. Combining it with other drugs that have similar effects, such as certain chemotherapy agents, may increase the risk of anemia, infections, or bleeding. Your healthcare provider will monitor your blood counts regularly to manage this risk.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Using NSAIDs like Meloxicam alongside Zejula may heighten the risk of bleeding due to their combined effects on platelets. It's advisable to consult your doctor before using NSAIDs during Zejula treatment.
Vaccines and Immunosuppressants: The safety of using Zejula with vaccines or immunosuppressant agents hasn't been thoroughly studied. Exercise caution and discuss with your healthcare provider before receiving vaccinations or starting immunosuppressive therapy while on Zejula.
Alcohol: While no direct interaction between Zejula and alcohol is known, consuming alcohol may exacerbate side effects like dizziness or nausea. It's best to limit or avoid alcohol during treatment.
Always inform your healthcare provider about all medications, supplements, and over-the-counter drugs you're taking to ensure safe and effective use of Zejula.
Is ZEJULA considered chemotherapy?
ZEJULA (niraparib) is not considered traditional chemotherapy. It is classified as a PARP inhibitor, which is a type of targeted therapy used in the treatment of certain types of cancer, such as ovarian cancer. Unlike chemotherapy, which targets rapidly dividing cells, PARP inhibitors specifically target cancer cells with certain genetic mutations.
How much does ZEJULA cost per month?
The cost of ZEJULA can vary based on factors such as insurance coverage, pharmacy, and location. Without insurance, the price can be several thousand dollars per month. Patients are advised to check with their insurance provider for specific coverage details and potential out-of-pocket costs. Additionally, there may be patient assistance programs available to help reduce the cost.
What is the classification of ZEJULA?
ZEJULA is classified as a poly (ADP-ribose) polymerase (PARP) inhibitor.
Does ZEJULA shrink tumors?
Zejula (niraparib) is a medication used as a maintenance treatment for certain types of ovarian, fallopian tube, or primary peritoneal cancer. It works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which can help prevent cancer cells from repairing their DNA, potentially slowing the growth of tumors. While Zejula is not specifically indicated to shrink tumors, it may help in controlling the progression of the disease.
How much does niraparib cost per month?
The cost of niraparib can vary based on factors such as location, insurance coverage, and pharmacy. On average, the monthly cost of niraparib without insurance can be several thousand dollars. Patients are encouraged to check with their specific pharmacy and insurance provider for the most accurate pricing and to explore any available financial assistance programs.